TY - JOUR
T1 - The intellectual developmental disorders Mexico study
T2 - Situational diagnosis, burden, genomics and intervention proposal
AU - Lazcano-Ponce, Eduardo
AU - Katz, Gregorio
AU - Rodríguez-Valentín, Rocío
AU - de Castro, Filipa
AU - Allen-Leigh, Betania
AU - Márquez-Caraveo, María Elena
AU - Ramírez-García, Miguel ángel
AU - Arroyo-García, Eduardo
AU - Medina-Mora, María Elena
AU - Ángeles, Gustavo
AU - Urquieta-Salomón, José Edmundo
AU - Salvador-Carulla, Luis
N1 - Publisher Copyright:
© 2016, salud pública de méxico.
PY - 2016
Y1 - 2016
N2 - Objective. This study aims to generate evidence on intellectual development disorders (IDD) in Mexico. Materials and methods. IDD disease burden will be estimated with a probabilistic model, using population-based surveys. Direct and indirect costs of catastrophic expenses of families with a member with an IDD will be evaluated. Genomic characterization of IDD will include: sequencing participant exomes and performing bioinformatics analyses to identify de novo or inherited variants through trio analysis; identifying genetic variants associated with IDD, and validating randomly selected variants by polymerase chain reaction (PCR) and sequencing or real-time quantitative PCR (qPCR). Delphi surveys will be done on best practices for IDD diagnosis and management. An external evaluation will employ qualitative case studies of two social and labor inclusion programs for people with IDD. Conclusions. The results will constitute scientific evidence for the design, promotion and evaluation of public policies, which are currently absent on IDD.
AB - Objective. This study aims to generate evidence on intellectual development disorders (IDD) in Mexico. Materials and methods. IDD disease burden will be estimated with a probabilistic model, using population-based surveys. Direct and indirect costs of catastrophic expenses of families with a member with an IDD will be evaluated. Genomic characterization of IDD will include: sequencing participant exomes and performing bioinformatics analyses to identify de novo or inherited variants through trio analysis; identifying genetic variants associated with IDD, and validating randomly selected variants by polymerase chain reaction (PCR) and sequencing or real-time quantitative PCR (qPCR). Delphi surveys will be done on best practices for IDD diagnosis and management. An external evaluation will employ qualitative case studies of two social and labor inclusion programs for people with IDD. Conclusions. The results will constitute scientific evidence for the design, promotion and evaluation of public policies, which are currently absent on IDD.
KW - ADHD
KW - Autistic disorder
KW - Burden
KW - Intellectual developmental disorders
KW - Mexico
UR - http://www.scopus.com/inward/record.url?scp=85026235955&partnerID=8YFLogxK
U2 - 10.21149/spm.v58i6.8267
DO - 10.21149/spm.v58i6.8267
M3 - Article
C2 - 28225946
AN - SCOPUS:85026235955
SN - 0036-3634
VL - 58
SP - 694
EP - 707
JO - Salud Publica de Mexico
JF - Salud Publica de Mexico
IS - 6
ER -